HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 79 filers reported holding HUMACYTE INC in Q2 2022. The put-call ratio across all filers is 1.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,845,573 | +4.2% | 3,018,967 | +1.7% | 0.00% | – |
| Q2 2023 | $8,490,299 | -7.4% | 2,968,636 | +0.1% | 0.00% | – |
| Q1 2023 | $9,165,796 | +52.7% | 2,966,277 | +4.3% | 0.00% | – |
| Q4 2022 | $6,003,505 | -31.0% | 2,845,263 | +6.5% | 0.00% | – |
| Q3 2022 | $8,707,000 | +1.4% | 2,671,123 | -0.1% | 0.00% | – |
| Q2 2022 | $8,584,000 | -49.8% | 2,674,005 | +10.4% | 0.00% | – |
| Q1 2022 | $17,099,000 | +101.9% | 2,422,020 | +107.3% | 0.00% | – |
| Q4 2021 | $8,469,000 | +151.5% | 1,168,232 | +302.7% | 0.00% | – |
| Q3 2021 | $3,368,000 | – | 290,109 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| York Capital Management Global Advisors, LLC | 2,291,397 | $16,177,000 | 4.71% |
| Endowment Wealth Management, Inc. | 96,618 | $682,000 | 0.72% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 36,171 | $255,000 | 0.24% |
| Prescott General Partners LLC | 625,100 | $4,413,000 | 0.20% |
| CenterBook Partners LP | 45,752 | $323,000 | 0.12% |
| Gladstone Institutional Advisory LLC | 144,867 | $1,023 | 0.07% |
| Exos Asset Management LLC | 18,609 | $131,000 | 0.06% |
| Sciencast Management LP | 26,300 | $182,000 | 0.04% |
| Y-Intercept (Hong Kong) Ltd | 17,125 | $121,000 | 0.03% |
| Kovack Advisors, Inc. | 31,500 | $222,000 | 0.02% |